Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from its Phase I/IIa study of IMC002, a VHH-based anti-CLDN18.2...
March Networks Presents New Cloud Storage at Intersec Dubai, Reducing Video Storage Costs by up to 80%
Latest product releases showcase new tiered cloud storage model paired with smarter video intelligence, security, and expanded edge hardware. DUBAI, United Arab Emirates, Jan. 12, 2026 /PRNewswire/ -- March Networks®, a global leader in intelligent...
Hyundai Motor Group Executive Chair Chung Presents 2026 Vision: Customer-Focused Transformation and AI-Driven Ecosystem Collaboration
Executive Chair Chung emphasizes customer-focused transformation and ecosystem strengthening to navigate evolving market dynamics and lead new industry standards Presents strategic priorities, including agile decision-making, ecosystem...
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early stage breast cancer. FLORENCE, Italy and NEW YORK,...
HanchorBio Presents First-in-Human Data of HCB101 Monotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma at ASH 2025
Early Phase 1 monotherapy data demonstrate cytopenia-sparing safety, broad pharmacologic window, and early clinical activity in relapsed/refractory non-Hodgkin lymphoma (NHL) TAIPEI, SHANGHAI, and SAN FRANCISCO, Dec. 8, 2025 /PRNewswire/ --...
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 8, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell...
Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance
Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product lifecycle LONDON, Dec. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of...
Nature Communications | Insilico Medicine Presents AI-empowered Dual-Action PROTAC Targeting PKMYT1
AI Designs a Novel RPOTAC from Scratch: Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its complex linker, demonstrating a powerful, end-to-end...
The St. Regis Macao Presents the House of Celebration this Festive Season
Timeless rituals and curated indulgences inspire a season of sophisticated wonder MACAO, Nov. 25, 2025 /PRNewswire/ -- The St. Regis Macao is delighted to unveil its enchanting programme of festive celebrations, transforming the hotel into the...
Phrozen Presents ARCO: Fast, Full-Color FDM 3D Printing for Creative Minds
TAIPEI, Nov. 10, 2025 /PRNewswire/ -- Phrozen, renowned for its leadership in resin 3D printing, expands its ecosystem with a refreshed look at ARCO, the company's first FDM 3D printer. Building on its reputation for high-precision printing, Phrozen...